Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Axatilimab in Healthy Japanese Male Participants: Results from a Phase 1, Randomized, Double-Blind, Dose-Escalation Study
DOI:
10.1007/s40261-025-01438-7
Publication Date:
2025-05-17T11:52:59Z
AUTHORS (6)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....